Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain

被引:43
|
作者
Boucard, AA [1 ]
Sauvé, SS [1 ]
Guillemette, G [1 ]
Escher, E [1 ]
Leduc, R [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada
关键词
binding pocket; G-protein-coupled receptor; p-benzoyl-L-phenylalanine; peptide mapping; photoaffinity labelling;
D O I
10.1042/BJ20021566
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A urotensin II (U-II) peptide analogue containing the photoreactive p-benzoyl-L-phenylaianine (Bz-Phe) in the sixth position was used to identify ligand-binding sites of the rat U-II receptor, also known as GPR14. [Bz-Phe(6)]U-II bound the receptor expressed in COS-7 cells with high affinity (IC50 0.7 nM) and was as potent as U-II in the agonist-induced production of inositol phosphate. Photolabelling of the U-II receptor with I-125-[Bz-Phe(6)]U-II resulted in the specific formation of a glycosylated I-125-[Bz-Phe(6)]U-II-U-II receptor complex of 60 kDa. Digestion of the 60 kDa complex with endoproteinase Glu-C generated a fragment of 17 kDa circumscribing the labelled fragment to residues 148-286. Digestion of the ligand-receptor complex with endoproteinase Arg-C produced a short peptide of 4 kDa corresponding to fragments 125-148, 167-192 or 210-233. CNBr treatment of the endoproteinase-Glu-C and -Arg-C fragments yielded 2 kDa fragments, defining the labelling site to methionine residues 184/185 of the fourth transmembrane domain. Photolabelling of two mutant receptors, M 184L/M185L and M184A/M185A, led to a significant decrease in the overall yield of covalent labelling. Taken together, our results indicate that position 6 of U-II normally occupied by phenylalanine would interact with Met(184) and/or Met(185) of the fourth transmembrane domain of the U-II receptor. This information should be of significant value in the study of the interactions between U-II and its cognate receptor.
引用
收藏
页码:829 / 838
页数:10
相关论文
共 50 条
  • [1] Characterization of the ligand-binding site of the rat urotensin receptor
    Krause, G
    Furkert, J
    Beyermann, M
    van der Giet, M
    Zidek, W
    Rosenthal, W
    Oksche, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 33 - 33
  • [2] Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain
    Gartlon, JE
    Ashmeade, T
    Duxon, M
    Hagan, JJ
    Jones, DNC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 493 (1-3) : 95 - 98
  • [3] Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14)
    Mori, M
    Sugo, T
    Abe, M
    Shimomura, Y
    Kurihara, M
    Kitada, C
    Kikuchi, K
    Shintani, Y
    Kurokawa, T
    Onda, H
    Nishimura, O
    Fujino, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) : 123 - 129
  • [4] Urotensin-II, the neuropeptide ligand for GPR14, induces C-fos in the rat brain
    Gartlon, J
    Ashmeade, T
    Duxon, M
    Hagan, JJ
    Jones, DNC
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136
  • [5] Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14
    Liu, QY
    Pong, SS
    Zeng, ZZ
    Zhang, Q
    Howard, AD
    Williams, DL
    Davidoff, M
    Wang, RP
    Austin, CP
    McDonald, TP
    Bai, C
    George, SR
    Evans, JF
    Caskey, CT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (01) : 174 - 178
  • [6] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    NATURE, 1999, 401 (6750) : 282 - 286
  • [7] Identification of transmembrane domain 1 & 2 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor
    Sainsily, Xavier
    Cabana, Jerome
    Holleran, Brian J.
    Escher, Emanuel
    Lavigne, Pierre
    Leduc, Richard
    BIOCHEMICAL PHARMACOLOGY, 2014, 92 (02) : 280 - 288
  • [8] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Robert S. Ames
    Henry M. Sarau
    Johathan K. Chambers
    Robert N. Willette
    Nambi V. Aiyar
    Anne M. Romanic
    Calvert S. Louden
    James J. Foley
    Charles F. Sauermelch
    Robert W. Coatney
    Zhaohui Ao
    Jyoti Disa
    Stephen D. Holmes
    Jeffrey M. Stadel
    John D. Martin
    Wu-Schyong Liu
    George I. Glover
    Shelagh Wilson
    Dean E. McNulty
    Catherine E. Ellis
    Nabil A. Elshourbagy
    Usman Shabon
    John J. Trill
    Douglas W. P. Hay
    Eliot H. Ohlstein
    Derk J. Bergsma
    Stephen A. Douglas
    Nature, 1999, 401 : 282 - 286
  • [9] Identification of transmembrane domain 3, 4 & 5 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor
    Sainsily, Xavier
    Cabana, Jerome
    Boulais, Philip E.
    Holleran, Brian J.
    Escher, Emanuel
    Lavigne, Pierre
    Leduc, Richard
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (11) : 1584 - 1593
  • [10] Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat
    Gong, H
    Wang, YX
    Zhu, YZ
    Wang, WW
    Wang, MJ
    Yao, T
    Zhu, YC
    JOURNAL OF APPLIED PHYSIOLOGY, 2004, 97 (06) : 2228 - 2235